Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Name:	us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.

Name:	us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.

Name:	us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.